ALIGNMT AI today emerged from stealth with $6.5 million in seed funding led by AIX Ventures, along with Sancus Ventures, Alumni Ventures, and Dent Capital. The company builds an AI governance platform for healthcare that aims to cut compliance overhead by about 50% and turn risk management from a blocker into a business enabler.
Why it matters
Hospitals and payers are rolling out AI for triage, documentation, revenue cycle, and clinical decision support. The pressure to deploy is high; so are the stakes. New standards and laws: CHAI transparency guidance, ONC HTI-1, DOJ expectations, and the EU AI Act, expect continuous risk assessment, documentation, and reporting. Most organizations still rely on manual spreadsheets and one-off audits. That gap creates cost, slows rollouts, and can erode trust if something goes wrong.
ALIGNMT AI offers a unified governance layer that sits alongside existing AI systems and data pipelines. The platform continuously monitors models in production without moving or exposing sensitive patient data, surfaces risks in real time, and auto-generates audit-ready artifacts mapped to major frameworks (CHAI, ONC HTI-1, DOJ, EU AI Act). The goal is simple: give executives and compliance teams a live view of what’s deployed, where it’s used, how it performs, and whether safeguards are holding—then automate the paperwork.
In practice, that means replacing fragmented manual processes with a single source of truth for model inventory, controls, and evidence. It means alerting when a model drifts, a required test is overdue, a fairness check fails, or a control isn’t enforced. And it means producing the reports auditors and regulators expect without weeks of hunting down screenshots and email chains.
Traction and customers
The company says it is working with major health systems, payers, and health-IT vendors, including EMR platforms and AI developers and counts Memorial Sloan Kettering as one of its major customers.
“Healthcare leaders are recognizing that AI governance is no longer optional; it’s critical infrastructure that must layer onto existing workflows to enable real-time risk monitoring,” said Andreea Bodnari, CEO of ALIGNMT AI. “This funding allows us to accelerate platform development and expand partnerships with leading institutions.”
“ALIGNMT.AI is the transformative solution hospitals and healthcare systems have been waiting for as they scale AI,” said Krish Ramadurai, Partner at AIX Ventures. “It gives clinical and compliance teams real-time visibility into every AI tool they deploy, surfacing issues instantly and helping them avoid costly mistakes. We’re already seeing providers cut compliance prep time by half, enabling confident rollouts that improve patient care safely and effectively.”
How it fits the market
AI in healthcare is shifting from pilots to production. That shift exposes a basic need: a shared control plane where clinical, compliance, security, and engineering teams can see the same facts and act on them. Vendors that provide this layer can help buyers move faster, reduce audit risk, and free up scarce data science capacity. In a budget-tight market, cutting the time spent preparing evidence by half is not just a cost line; it can unlock stalled deployments.
The seed round will support hiring in engineering and go-to-market, deeper integrations with health-system tooling, and expanded partnerships with buyers that want to deploy AI responsibly at scale. Expect more automation around continuous monitoring, stronger mapping to emerging rules, and features that make audit cycles faster and more predictable.
AI can improve patient outcomes, but only if hospitals can prove systems are safe, fair, and compliant, every day, not once a year. ALIGNMT AI is betting that a unified, governance-first platform is the fastest way to do that at enterprise scale.
Healthcare organizations can learn more at alignmt.ai.
